Pharmacologic management of type 2 diabetes in the elderly: Overview of treatment

da Silva, Barbara A.
July 2000
Formulary;Jul2000, Vol. 35 Issue 7, p580
Academic Journal
Evaluates treatment options for type 2 diabetes in the elderly. Complications requiring special consideration in the elderly; Glycemic control techniques; Oral hypoglycemic medications; Combination therapy; Adverse effects; Drug interactions; Dosage administration.


Related Articles

  • Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People. Papa, Giuseppe; Purrello, Francesco; Fedele, Viviana; Leotta, Carmelo; Rizzo, Maria Rosaria; Paolisso, Giuseppe; Fioravanti, Marisa; Solerte, Sebastiano Bruno // Diabetes Care;Aug2006, Vol. 29 Issue 8, p1918 

    The article presents a study that assesses the safety of repaglinide versus glibenclamide in older people, in terms of hypoglycemia and adverse events. A total of 88 patients completed the trial. After titration, the mean therapeutic dose was 4.1 mg/day for repaglinide period and 6.1 mg/day for...

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

  • Combination Therapy for Type 2 Diabetes. Bell, David S. H. // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1812 

    Editorial. Comments on the combination therapy for type 2 diabetes. Effectiveness of sulfonylurea as treatment for type 2 diabetes; Examination of the insulin therapy; Information on the combined insulin and oral therapy.

  • Management of Type 2 Diabetes Mellitus in Older Adults. Kyung Soo Kim; Soo Kyung Kim; Kyung Mi Sung; Yong Wook Cho; Seok Won Park // Diabetes & Metabolism Journal;Oct2012, Vol. 36 Issue 5, p336 

    In the near future, the majority of patients with diabetes will be adults aged 65 or older. Unlike young adults with diabetes, elderly diabetic people may be affected by a variety of comorbid conditions such as depression, cognitive impairment, muscle weakness (sarcopenia), falls and fractures,...

  • Efectos de un programa de ejercicio vibratorio de 12 semanas sobre la calidad de vida y la satisfacción con el tratamiento en pacientes adultos-mayores afectados por diabetes mellitus tipo 2. Alfonso Rosa, R.Mª; Del Pozo-Cruz, J.; Sañudo-Corrales, B.; Haro González, M.; Fuentes Aragón, A.; Del Pozo-Cruz, B. // Revista Kronos;ene-jun2013, Vol. 12 Issue 1, p9 

    The aim of This Study was to analyze the effects of 12-wk whole body vibration programme n quality of life and satisfaction with treatment among elderly people with type 2 diabetes (DM2). A randomized controlled trial was conducted with 39 (19 experimental group and 20 control group). Quality of...

  • EPIDEMIOLOGY--AGING.  // Diabetes;2015 Supplement, Vol. 64, pA677 

    The article presents abstracts on medical topics, namely, the studies on the long-term Liraglutide treatment in elderly diabetic Spanish patients, the relationships between magnesium levels and glucose regulation and diabetes duration in elderly patients with type 2 diabetes, and the association...

  • Diabetes Surgery: A New Approach to an Old Disease. Rubino, Francesco; Moo, Tracy-Ann; Rosen, Daniel J.; Dakin, Greg F.; Pomp, Alfons // Diabetes Care;Nov2009 Supplement, Vol. 32, pS368 

    The article focuses on diabetes surgery as a new approach to treat the disease. It cites the increase in the number of older people who have diabetes from 1994 to 2004. Studies are said to confirm the effectiveness of bariatric surgery for the treatment of type 2 diabetes. It mentions some of...

  • Using insulin in type 2 diabetes. Colwell, John A.; Feinglos, Mark N. // Patient Care;7/30/2001, Vol. 35 Issue 14, p36 

    Focuses on the role of insulin in the treatment of type 2 diabetes. Etiology of the disease; Rationale for using insulin; Treatment recommended by the American Diabetes Association; Side effects of insulin. INSET: Time-efficient management of patients with type 2 diabetes.

  • Glucosidase inhibitor for NIDDM.  // Geriatrics;Apr97, Vol. 52 Issue 4, p36 

    Presents information about miglitol, an alpha-glucosidase inhibitor for the treatment of noninsulin-dependent diabetes mellitus (NIDDM). Effectivity of miglitol in treating NIDDM; Recommended dosage for taking miglitol; Contraindication of miglitol; Adverse reactions of miglitol.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics